Northern Trust Corp lowered its stake in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 0.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 852,532 shares of the company’s stock after selling 3,677 shares during the period. Northern Trust Corp owned about 1.65% of Prestige Consumer Healthcare worth $26,326,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. First Hawaiian Bank lifted its holdings in Prestige Consumer Healthcare by 218.4% in the fourth quarter. First Hawaiian Bank now owns 1,210 shares of the company’s stock valued at $37,000 after acquiring an additional 830 shares during the last quarter. FNY Investment Advisers LLC acquired a new position in Prestige Consumer Healthcare in the fourth quarter valued at approximately $37,000. First Quadrant L P CA acquired a new position in Prestige Consumer Healthcare in the fourth quarter valued at approximately $72,000. CWM LLC lifted its holdings in Prestige Consumer Healthcare by 31,718.2% in the fourth quarter. CWM LLC now owns 3,500 shares of the company’s stock valued at $108,000 after acquiring an additional 3,489 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its stake in Prestige Consumer Healthcare by 338.0% during the third quarter. Tower Research Capital LLC TRC now owns 3,754 shares of the company’s stock worth $142,000 after purchasing an additional 2,897 shares in the last quarter.
NYSE:PBH traded up $0.43 during trading hours on Friday, hitting $28.08. The company’s stock had a trading volume of 338,138 shares, compared to its average volume of 601,188. The firm has a market capitalization of $1.45 billion, a PE ratio of 10.88, a price-to-earnings-growth ratio of 1.58 and a beta of 0.98. The company has a debt-to-equity ratio of 1.49, a current ratio of 2.28 and a quick ratio of 1.34. Prestige Consumer Healthcare Inc has a 52-week low of $26.25 and a 52-week high of $41.76.
A number of research firms have commented on PBH. Zacks Investment Research upgraded Prestige Consumer Healthcare from a “sell” rating to a “hold” rating in a research note on Tuesday, April 16th. Desjardins cut Prestige Consumer Healthcare to a “hold” rating and set a $88.00 price target on the stock. in a research note on Wednesday, February 13th. Royal Bank of Canada restated a “buy” rating and set a $97.00 price target on shares of Prestige Consumer Healthcare in a research note on Friday, March 15th. ValuEngine lowered Prestige Consumer Healthcare from a “sell” rating to a “strong sell” rating in a research report on Thursday, January 10th. Finally, Raymond James lowered Prestige Consumer Healthcare from an “outperform” rating to a “market perform” rating and set a $28.40 price objective on the stock. in a research report on Tuesday, January 15th. One analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $54.07.
COPYRIGHT VIOLATION WARNING: This story was published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The correct version of this story can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/northern-trust-corp-cuts-stake-in-prestige-consumer-healthcare-inc-pbh.html.
Prestige Consumer Healthcare Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Read More: What is intrinsic value?
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.